nafoxidine has been researched along with Cell Transformation, Neoplastic in 2 studies
Nafoxidine: An estrogen antagonist that has been used in the treatment of breast cancer.
Cell Transformation, Neoplastic: Cell changes manifested by escape from control mechanisms, increased growth potential, alterations in the cell surface, karyotypic abnormalities, morphological and biochemical deviations from the norm, and other attributes conferring the ability to invade, metastasize, and kill.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| van Marle, J | 1 |
| Lindeman, J | 1 |
| Ariens, AT | 1 |
| Labruyère, W | 1 |
| van Weeren-Kramer, J | 1 |
| Jordan, VC | 1 |
| Gottardis, MM | 1 |
| Satyaswaroop, PG | 1 |
2 other studies available for nafoxidine and Cell Transformation, Neoplastic
| Article | Year |
|---|---|
Estrogen receptors in human breast cancer. I. Specificity of the histochemical localization of estrogen receptors using an estrogen-albumin FITC complex.
Topics: Animals; Breast Neoplasms; Cattle; Cell Transformation, Neoplastic; Estrogens; Fluorescein-5-isothio | 1982 |
Tamoxifen-stimulated growth of human endometrial carcinoma.
Topics: Animals; Antineoplastic Agents; Cell Transformation, Neoplastic; Clomiphene; Enclomiphene; Endometri | 1991 |